From: Cardiovascular risk in pediatric-onset rheumatological diseases
Source | Number (% female) | Age (years) | Disease duration (years) | Frequency of CIMT assessment | CIMT progression (mm/year) |
---|---|---|---|---|---|
Huang and colleagues [20] | 76 (90%) | 15.0 ± 3.5 | 2.7 ± 2.5 | Baseline and every 6 monthsa | 0.0016 ± 0.0016b |
Schanberg and colleagues [26] | 108 (82%)c | 15.8 ± 2.5 | 2.5 ± 2.3 | Baseline, 6, 12, 24 and 36 months | 0.0024 (0.0007, 0.0040)d |
 | 113 (84%)e | 15.7 ± 2.8 | 2.7 ± 2.4 |  | 0.0010 (-0.0006, 0.0026)d |